Glaxosmithkline | GSK - Liquidités





Liquidités Changement Date
AbbVie USD 6.57B 2.82B 2026-06
Amgen USD 13.99B 1.95B 2026-06
AstraZeneca USD 4.89B 2.67B 2026-06
Aurora Cannabis CAD 64.69M 8.33M 2026-03
Bausch Health Companies USD 1.83B 526M 2026-06
Bristol-Myers Squibb USD 8.72B 852M 2026-06
Canopy Growth CAD 364.68M 6.64M 2026-03
Corcept Therapeutics USD 111.04M 2.3M 2026-06
Drreddys Laboratories INR 15.37B 3.29B 2026-03
Eli Lilly USD 8.95B 3.67B 2026-06
GlaxoSmithKline GBP 3.44B 292M 2026-03
Glaxosmithkline GBP 3.44B 146M 2026-03
J&J USD 20.42B 1.27B 2026-06
Merck USD 6.85B 1.52B 2026-06
Novartis USD 7.62B 739M 2026-06
Pacira USD 205.88M 61.57M 2026-06
Perrigo USD 357.2M 174.4M 2026-03
Pfizer USD 976M 727M 2026-06
Phibro Animal Health USD 54.93M 557K 2026-03
Prestige Brands USD 89.13M 25.26M 2026-06
Roche Holding CHF 7.55B 579M 2025-06
Sanofi EUR 6.35B 806M 2026-06
Supernus Pharmaceuticals USD 179.95M 4.92M 2026-06
Takeda JPY 460.98B 134.07B 2026-06
Teva Pharmaceutical Industries USD 3.74B 185M 2026-03
Zoetis USD 1.48B 465M 2026-06